Spirulina Supplementation to the Semen Extender Influences the Quality and Antioxidant Parameters of Chilled or Cryopreserved Arabian Stallion Spermatozoa.

The present study attempted to investigate the effect of various concentrations of spirulina platensis additions to the semen extender on Arabian stallion spermatozoa quality. Semen samples were collected with artificial vagina from five fertile stallions and diluted with an extender containing spirulina (2, 4, 6, and 8 mg/100 mL) or without spirulina (control). Aliquots of diluted semen were cooled (5°C, 90 minutes) and frozen (-196°C, 7 days), then physical traits of thawed spermatozoa were examined. Furthermore, antioxidant activities of superoxide dismutase (SOD), glutathione reductase (GSR), total antioxidant capacity (TAC), and malondialdehyde (MDA) were measured in post-cooling and freezing spermatozoa. The results indicated that spirulina supplemented with the extender had no effect (P >.05) on sperm quality parameters and antioxidant activities after cooling. However, adding 6 mg spirulina/100 mL to the freezing extender improved (P < .05) the speed parameters and total motility percentage of frozen/thawed spermatozoa. Besides, supplementation of freezing extender with the previous level increased (P < .05) TAC, SOD and GSR concentrations/activities (0.86 ± 0.32 mM/L, 323.70 ± 12.81 U/mL, and 38.65 ± 1.90 U/mL, respectively) compared with the control (0.70 ± 0.25 mM/L, 165.80 ± 8.12 U/mL, and 25.70 ± 1.83 U/mL, respectively). While, lipid peroxidation of the frozen-thawed semen was reduced (P < .05, 17.97 ± 1.30 µmol/ L) compared with the control (29.39 ± 1.89 µmol/ L). Accordingly, the present results revealed that additions of 6 mg spirulina/100 mL to the freezing extender improved semen quality and reduced cryodamage of the Arabian stallion spermatozoa.

Consequences of twinning induction to Noemi ewes by a recombinant human follicle-stimulating hormone compared with pituitary-derived porcine follicle-stimulating hormone on follicular dynamics, maternal biochemical attributes, and neonatal traits.

AIM: The aim of this study was to investigate the effectiveness of using recombinant human follicle-stimulating hormone (FSH) compared with pituitary-derived porcine FSH given as one dose or multiple doses on the neonatal traits, follicular dynamics, and maternal blood biochemical constituents in Noemi ewes. MATERIALS AND METHODS: A 3×2 factorial arrangement was designed utilizing 60 adults Noemi ewes to test the effects of using two sources of FSH (human vs. porcine) in addition to control, either given as a single total dose or six descending doses to provoke twinning. Six treatments (T) were tested (n=10 ewes/T). C1 and C6 served as control ewes given saline as one dose and six doses, respectively; H1 and H6 ewes were given human FSH as one and six doses; and P1 and P6 ewes were given porcine FSH similar to the above treatments. Saline and/or FSH administration were administered at days 8, 9, and 10 of the 10-day controlled internal drug release (CIDR) implant. At CIDR removal, fertile rams were used for natural mating. Blood samples for the assessment of serum metabolites were collected. RESULTS: Twinning increased in FSH-treated ewes than control. However, giving FSH of either source as a single dose resulted in a higher incidence of stillbirths. Pregnancy rates were 30, 40, 50, 60, 70, and 80% in C1, C6, P1, P6, H1, and H6, respectively. Respective percent of ewes delivering twins/multiple birth was 0, 0, 80, 66.7, 71.4, and 87.5%. FSH of human source was more efficient for folliculogenesis than porcine FSH. Administration of FSH increased blood cholesterol, decreased high-density lipoprotein; however, low-density lipoprotein levels were not different than control. Moreover, an interaction (p<0.05) exists between source and type of FSH administration on blood glucose. Six doses of FSH elevated blood protein. Blood albumin decreased by porcine-FSH but not affected by human-FSH. Blood globulins were not different due to source of FSH, whereas giving FSH as six doses increased globulins than in single-dose protocol. Contrariwise, an interaction was found between source and type of FSH administration on elevating the activity of alanine aminotransferase and reducing the activity of aspartate aminotransferase. CONCLUSION: Administration of human FSH at 180 IU in six descending doses resulted in the best neonatal outcomes and maternal health in Noemi ewes.